The University of Rochester held a tribute program entitled “A Celebration of a Pioneering Career in Neuromuscular Disease” May 31- June 1, 2018 in honor and celebration of Richard T. Moxley’s distinguished career as a clinician and researcher with a significant focus and commitment to myotonic dystrophy. MDF created a short video to celebrate Dr. Moxley's incredible impact.
MDF strongly encourages DM investigators to apply for research grant support from the Department of Defense's Peer-Reviewed Medical Research Program (PRMRP).
The Myotonic Dystrophy Foundation honored both Senator Dick Durbin and Senator Diane Feinstein with MDF Congressional Leadership Awards for their outstanding work and support in getting myotonic dystrophy added as an eligible research area in the U.S. Department of Defense (DOD) Peer-Reviewed Medical Research Program (PRMRP) for Fiscal Year 2018 (FY18).
Insights on the mechanisms that underlie muscle atrophy in DM are provided by studies in a new mouse model.
The RNA binding protein, rbFOX1, competes with MBNL in binding to CCUGexp, but not CUGexp repeats, and thereby mitigates DM2.